This practice-enhancing volume assembles the latest innovative thinking on working with clients who have both mental health diagnoses and substance use disorders. Diagnosis is a central focus of the coverage, untangling the often-knotty considerations surrounding dual diagnosis and the complex issues surrounding treatment even in frequently seen combinations (e.g., depression/alcohol abuse). The section on practice emphasizes meeting patients where they are and making use of their community, cultural, and spiritual contexts in crafting interventions. And the book’s ambitious chapters on professional development describe training programs with the potential to produce the next generation of responsive, knowledgeable, and flexible therapists. Among the topics covered: · Comprehensive assessment of substance abuse and addiction risk in adolescents. · The relationship between attachment and addiction. · Addiction in the community: the role of emergency services. · Substance use during and after major crisis and disaster: a practitioner’s guide. · Practice, advocacy, and outreach: perspectives on addiction services. · Teaching the importance of developing the therapeutic relationship. New Directions in Treatment, Education, and Outreach for Mental Health and Addiction equips health and clinical psychologists, social workers, and addiction counselors and educators with a well-rounded understanding of a growing population, and a wealth of perspectives on effective new interventions.

Becoming a Mental Health Counselor is a guide for students on the path to becoming licensed mental health therapists, as well as those just starting their careers. Filled with practical advice and tips, this book guides the reader through early career milestones of psychotherapists, including professional identity development, applying for jobs, and obtaining licensure. Volungis also discusses the reality of the profession, emphasizing the importance of self-care, ethics, personal identity, and managing expectations. The book concludes with an exploration of private practice and the next steps in the career ladder. Ideally suited for professional development courses, this volume helps students prepare for life outside of school. It shows them how to transform the knowledge they’ve gained into a successful career.

Based on current research and theory, Substance Use Disorders and Addictions, Second Edition examines co-occurring psychiatric disorders as the norm with substance use disorders and addictions. With more than 25 years of experience in the field as a clinician, a researcher, a program developer, and an instructor, Keith Morgen encourages a holistic approach to working with individuals, using three case examples throughout the text to encourage the sequential application of concepts to co-occurring disorders. The second edition includes coverage of the DSM-5-TR diagnostic criteria, the 4th edition ASAM Placement Criteria, and the 2024 CACREP and MPCAC Counseling Accreditation standards. This second edition comes with over 300 new and recent scholarly sources. Readers will benefit from this applied and cutting-edge introduction to the field.

Neuropsychopharmacology reviews the principles of pharmacology with a focus on the central nervous system and autonomic nervous system. Beyond autonomic and central nervous system pharmacology, this volume uniquely discusses psychiatric disorders and the pharmacological interventions that are available for conditions including depression, schizophrenia and anxiety disorders. With a focus on these specific body systems, readers will see end-of-chapter questions that offer real-world case studies, as well as multiple-choice questions for further learning. Beneficial features and content also include two extensive examination tests, which each contain 100 questions for better learning or to be used in teaching, and a glossary. Helpful appendices cover high-alert medications and toxicology effects on the nervous system. Each chapter will contain classifications of medications, pharmacokinetics, mechanism of action, clinical indications and toxicities. - Describes pharmacology principles pertaining to the central and autonomic nervous system - Identifies pharmacological interventions for psychiatric disorders including current evidence-based interventions for depression, schizophrenia and anxiety disorders - Features chapter outlines, end-of-chapter questions, real-world case studies and examinations for deeper learning or teaching

A comprehensive guide for clinicians working with patients engaging in self-injury, this book provides information on clinical conceptualization, risk and protective factors, ways to assess for NSSI, treatment approaches and strategies, and early intervention and prevention strategies. Focusing on ethical and cultural considerations unique to schools, clinical agencies, and private-practice settings, the authors provide a practical and in-depth discussion of clinical theory. Procedures for determining risk and the potential problems with risk assessment, especially concerning suicide risk, are addressed. In addition to numerous exercises, examples, and suggestions for practical interventions, the book includes a variety of detailed worksheets and resources to expand readers’ level of understanding, monitor emerging trends, and provide a context for extended training. Several case studies are discussed and analyzed in order to highlight specific aspects of clinical conceptualization and treatment strategies. Drawn from a wide range of treatment populations and issues, this book is a valuable resource for clinicians and supervisors. The authors integrate outcomes-based research strategies and evidenced-based tools to help clinicians work with clients from diverse backgrounds.

This leading course text and practitioner reference has been extensively revised with 90% new content, covering a broader range of child and adolescent problems in more concise chapters. Prominent authorities provide a comprehensive framework for evidence-based assessment. Presented are methods and tools for developing effective diagnoses and case formulations, building strong treatment plans, monitoring progress, and documenting outcomes. Chapters are packed with practical guidance, handy tables, and sample instruments. Illustrative case material is included. Prior edition title: Assessment of Childhood Disorders, Fourth Edition, edited by Eric J. Mash and Russell A. Barkley. New to This Edition *Many new authors and topics, reflecting over a decade of research and clinical advances. *Updated for DSM-5 and ICD-11. *Chapters on additional disorders: obsessive–compulsive disorder, persistent complex bereavement, and body dysmorphic disorder. *Chapters on transdiagnostic concerns: sleep problems, risky behaviors, and life stressors. *Four chapters on the "whys" and "hows" of using assessment in each phase of treatment. *Disorder-specific "starter kits"--lists of essential checklists, rating scales, interviews, and progress measures, including links to exemplary free measures online. See also the editors' Treatment of Disorders in Childhood and Adolescence, Fourth Edition.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.